Storm Therapeutics Appoints Nobel Prize Winner Thomas Cech as Scientific AdvisorStorm Therapeutics today announced the appointment of Nobel Prize Winner Professor Thomas Cech as a Scientific Advisor. This appointment follows STORM Therapeutics’ successful Series A Financing Extension … more ➔
Congenica Appoints New CEOCongenica, a global provider of clinical genomics interpretation software, today announced the appointment of its new Chief Executive Officer David Atkins, Ph.D. Based at the Company’s headquarters in … more ➔
Emil Billbäck appointed CEO of BONESUPPORTBONESUPPORT (Nasdaq Stockholm: BONEX) announces that the Board of Directors has appointed Emil Billbäck as the new CEO of BONESUPPORT HOLDING AB. Mr. Billbäck has over 20 years management experience … more ➔
Synpromics Appoints Sarah Haecker Meeks as VP of BDSynpromics Ltd today announced the appointment of Sarah Haecker Meeks, PhD to the position of Vice President, Business Development. more ➔
Glythera appoints Chief Scientific OfficerGlythera Limited is pleased to announce the appointment of Dr Robert Lutz as Chief Scientific Officer. Dr Lutz will lead the advancement of Glythera’s portfolio of Antibody Drug Conjugates (ADCs) in … more ➔
Sterna Biologicals appoints CEO sterna biologicals GmbH & Co. KG announced today that the Company has appointed Christian M. Pangratz as Chief Executive Officer. more ➔
Sanifit appoints Cris Calsada as CFOLaboratoris Sanifit S.L., a clinical-stage biopharmaceutical company focused on treatments for calcification disorders, today announced the appointment of Cris Calsada as Chief Financial Officer. more ➔
Targovax appoints Michael Bogenstaetter as CBOTargovax ASA (OSE: TRVX) announces that Michael Bogenstaetter has been appointed as the Company’s Chief Business Officer (CBO). He will take up this role in January 2018. more ➔
Sally Ann Forsyth to join SBCStevenage Bioscience Catalyst (SBC) has announced that Dr. Sally Ann Forsyth is set to join the company as CEO in March 2018. more ➔
Avillion names new Chief Business OfficerLate-stage pharmaceuticals financing and co-development specialist Avillion LLP has named Kathryn J. Gregory Chief Business Officer. more ➔
